X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (9) 9
index medicus (9) 9
male (9) 9
ophthalmology (8) 8
double-blind method (7) 7
consulting services (6) 6
middle aged (6) 6
adult (5) 5
dropsy (5) 5
edema (5) 5
treatment outcome (5) 5
vascular endothelial growth factor (5) 5
aged (4) 4
analysis (4) 4
multiple sclerosis (4) 4
neurology (4) 4
ranibizumab (4) 4
retreatment (4) 4
visual acuity - physiology (4) 4
clinical neurology (3) 3
drug therapy (3) 3
interferon-beta - therapeutic use (3) 3
internal medicine (3) 3
intravitreal injections (3) 3
macular degeneration (3) 3
ms (3) 3
multiple sclerosis - drug therapy (3) 3
receptors, vascular endothelial growth factor (3) 3
recombinant fusion proteins - administration & dosage (3) 3
retinal diseases (3) 3
adjuvants, immunologic - administration & dosage (2) 2
adolescent (2) 2
clinical trials (2) 2
definite (2) 2
demyelinating event (2) 2
diabetes mellitus, type 1 - complications (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetic retinopathy (2) 2
diabetic retinopathy - drug therapy (2) 2
diabetic retinopathy - physiopathology (2) 2
diabetic retinopathy - surgery (2) 2
diabetic retinopathy - therapy (2) 2
diagnostic-criteria (2) 2
disability (2) 2
endothelial growth-factor (2) 2
endothelium (2) 2
fluorescein angiography (2) 2
follow-up (2) 2
follow-up studies (2) 2
glatiramer acetate (2) 2
guidelines (2) 2
impairment (2) 2
interferon beta-1b (2) 2
interferon-beta (2) 2
interferon-beta - administration & dosage (2) 2
laser coagulation (2) 2
macular edema - drug therapy (2) 2
macular edema - physiopathology (2) 2
macular edema - surgery (2) 2
macular edema - therapy (2) 2
medical colleges (2) 2
medicine, general & internal (2) 2
physiological aspects (2) 2
recombinant fusion proteins - adverse effects (2) 2
recombinant fusion proteins - therapeutic use (2) 2
retinopathy (2) 2
risk assessment (2) 2
statistical analysis (2) 2
time factors (2) 2
tomography, optical coherence (2) 2
trial (2) 2
young adult (2) 2
abridged index medicus (1) 1
adjuvants, immunologic (1) 1
adjuvants, immunologic - adverse effects (1) 1
adjuvants, immunologic - economics (1) 1
adjuvants, immunologic - therapeutic use (1) 1
administration, cutaneous (1) 1
aged, 80 and over (1) 1
aging - genetics (1) 1
alemtuzumab (1) 1
algorithms (1) 1
alleles (1) 1
alternative splicing (1) 1
alternative splicing - physiology (1) 1
alzheimer disease - genetics (1) 1
alzheimer disease - metabolism (1) 1
alzheimer's disease (1) 1
alzheimer8s disease (1) 1
alzheimers-disease (1) 1
amino acid sequence (1) 1
amyloid beta-protein precursor - biosynthesis (1) 1
amyloid beta-protein precursor - chemistry (1) 1
amyloid beta-protein precursor - genetics (1) 1
amyloid precursor protein (1) 1
amyloid precursor-like protein (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
animals (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1414 - 1420.e1
Purpose To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) for the treatment of macular edema secondary to central retinal vein... 
Ophthalmology | TRIAL | BEVACIZUMAB | PHASE-III | SECONDARY | OPHTHALMOLOGY | VEGF TRAP-EYE | RANIBIZUMAB | Dropsy | Edema | Retinal diseases | Consulting services
Journal Article
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 9, pp. 1819 - 1826
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 5, pp. 1024 - 1032
Objective To assess the efficacy and safety of intravitreal vascular endothelial growth factor (VEGF) Trap-Eye in eyes with macular edema secondary to central... 
Ophthalmology | Dropsy | Edema | Endothelial growth factors | Vascular endothelial growth factor | Consulting services | Retinal diseases
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 12, pp. 1111 - 1119
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 10, pp. 889 - 897
Summary Background The aim of the Betaferon Efficacy Yielding Outcomes of a New Dose (BEYOND) trial was to compare the efficacy, safety, and tolerability of... 
Neurology
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
Journal Article